Udyan Biomatrix Private Limited
Founded in 2017 and headquartered in Karnataka, India.
2017 | Bidar, Karnataka (India) | Active
Udyan Biomatrix Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 85.20 K
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -28.04%
- Profit Growth -60.90%
- Ebitda 103.25%
- Net Worth 8.93%
- Total Assets 61.05%
About Udyan Biomatrix
Udyan Biomatrix Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2017 (Eight years and one month 22 days old ). Its registered office is in Bidar, Karnataka, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 85.20 K , as per Ministry of Corporate Affairs (MCA) records.
Nutanben Singh and Seema Singh serve as directors at the Company.
Company Details
- Location
Bidar, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KA2017PTC098967
- Company No.
098967
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Business Services
Who are the key members and board of directors at Udyan Biomatrix?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nutanben Singh  | Director | 03-Jan-2017 | Current |
| Seema Singh | Director | 03-Jan-2017 | Current |
Financial Performance of Udyan Biomatrix.
Udyan Biomatrix Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 28.04% decrease. The company also saw a substantial fall in profitability, with a 60.9% decrease in profit. The company's net worth moved up by a moderate rise of 8.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Udyan Biomatrix?
In 2017, Udyan Biomatrix had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Udyan Herbomatrix Private Limited
Nutanben Singh and Seema Singh are mutual person
- Wabi Sabi Gifting Private Limited
Nutanben Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Udyan Biomatrix?
Unlock and access historical data on people associated with Udyan Biomatrix, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Udyan Biomatrix, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Udyan Biomatrix's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
